课题基金 / 基金详情

Analysis of metabolic changes associated with cetuximab resistance in oral squamous cell carcinoma and designing of new treatment

Analysis of metabolic changes associated with cetuximab resistance in oral squamous cell carcinoma and designing of new treatment
口腔鳞状细胞癌西妥昔单抗耐药相关代谢变化分析及新疗法设计
批准号:
16K20613
负责人:
Yoshikawa Momoko
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2016
资助国家:
日本
项目状态:
已结题
起止时间:
2016-04-01 至 2019-03-31

项目摘要

项目成果

Yoshikawa Momoko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines
通过负载顺铂的纳米药物的受控细胞内导航根除头颈肿瘤中的 CD44 变异阳性群体
DOI: 10.1016/j.jconrel.2016.03.038
发表时间: 2016
期刊: Journal of Controlled Release
影响因子: 10.8
作者: [Ming Wang, Yutaka Miura, Kenji Tsuchihashi, Kazuki Miyano, Osamu Nagano, Momoko Yoshikawa, Ami Tanabe, Jun Makino, Yuki Mochida, Nobuhiro Nishiyama, Hideyuki Saya, Horacio Cabral, Kazunori Kataoka]
通讯作者: Kazunori Kataoka
DOI: 10.1177/0022034518759278
发表时间: 2018-03
期刊: Journal of Dental Research
影响因子: 7.6
作者: [T. Ouchi;S. Morikawa;S. Shibata;M. Takahashi;M. Yoshikawa;T. Soma;H. Miyashita;W. Muraoka;K. Kameyama;H. Kawana;Y. Arima;H. Saya;H. Okano;T. Nakagawa;S. Asoda]
通讯作者: T. Ouchi;S. Morikawa;S. Shibata;M. Takahashi;M. Yoshikawa;T. Soma;H. Miyashita;W. Muraoka;K. Kameyama;H. Kawana;Y. Arima;H. Saya;H. Okano;T. Nakagawa;S. Asoda
Characterization of CD44v-positive oral cancer stem cells using PDX model and establishment of novel drug therapy
  • 批准号:
    20K10103
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2020
  • 负责人:
    Yoshikawa Momoko
  • 依托单位:
Development of the therapy for cetuximab-resistant oral squamous cell carcinoma cells
  • 批准号:
    26861579
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.5万
  • 财政年份:
    2014
  • 负责人:
    Yoshikawa Momoko
  • 依托单位:
海外基金